Peer-reviewed

NurOwn®, phase 2, randomized, clinical trial in patients with ALS

The primary publication of the randomized, placebo-controlled Phase 2 study of NurOwn in participants with ALS.

Citation details

Journal
Neurology
Published
Type
Peer-reviewed
Topic
Amyotrophic Lateral Sclerosis